Viatris Inc

1 active facility, size not stated, next covenant test Sep 30, 2026. VTRS

Pharmaceutical Preparations

Recent changes

  1. Jul 1, 2026Viatris Inc signs AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENTSEC ↗

Net leverage: when the limit steps, and which way the company's ratio has been moving.

20264.72x4.17x3.62xToday
Tested quarterlyEstimated above the limit*ratio 4.59x, estimated, vs 3.75x limit in force at Jun 30, 20263.75x
The Borrower will not permit the Consolidated Leverage Ratio as of the last day of each fiscal quarter ending after the Closing Date to exceed 3.75 to 1.00
Read the filing on sec.gov ↗

* Estimates use reported financials; credit agreements usually add back items that XBRL does not capture.

Download CSV · Download JSON

AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT

Signed Jul 1, 2026

Committed
n/a
Matures
n/a
Agent
MIZUHO BANK, LTD.
TrancheSizeMaturesMargin
Term LoanJPY $40bnn/a100–135 bps

Priced over Other, floor 0 bps (Term Loan A).

LevelConditionMarginUnused fee
Level 1> Baa2 / BBB / BBB100 bpsn/a
Level 2Baa3 / BBB- / BBB-110 bpsn/a
Level 3≤ Ba1 / BB+ / BB+135 bpsn/a

§1.01

Lenders: MIZUHO BANK, LTD., MUFG BANK, LTD., SUMITOMO MITSUI BANKING CORPORATION

No amendments on file yet.

Report an error

Email [email protected].